Prevalence of Clindamycin-resistant Staphylococcus aureus Induced by Macrolide Resistance, Iran, 2019-2021

Fateh Dizji, Pegah; Khosravy, Maryam; Saeedi, Ali Asghar; Asli, Maryam; Sepahvand, Shahriar; Darvishi, Mohammad

doi:10.30699/ijmm.17.2.256

year 17, Issue 2 (March - April 2023) Iran J Med Microbiol 2023, 17(2): 256-261 | Back to browse issues page

‎ 10.30699/ijmm.17.2.256

Mendeley

Zotero

RefWorks

Fateh Dizji P, Khosravy M, Saeedi A A, Asli M, Sepahvand S, Darvishi M. Prevalence of Clindamycin-resistant Staphylococcus aureus Induced by Macrolide Resistance, Iran, 2019-2021. Iran J Med Microbiol 2023; 17 (2) :256-261
URL: http://ijmm.ir/article-1-1808-en.html

Prevalence of Clindamycin-resistant Staphylococcus aureus Induced by Macrolide Resistance, Iran, 2019-2021

Pegah Fateh Dizji¹

, Maryam Khosravy²

, Ali Asghar Saeedi³

, Maryam Asli³

, Shahriar Sepahvand⁴

, Mohammad Darvishi

⁵

1- General Practitioner, Researcher, Medical Branch of Islamic Azad University of Tehran, Tehran, Iran
2- PhD of Microbiology, Besaat Hospital, Aja university of Medical Sciences, Tehran, Iran
3- Assistant Professor, Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Aja university of Medical Sciences, Tehran, Iran
4- Department of Microbiology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
5- Associate Professor, Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Aja university of Medical Sciences, Tehran, Iran , darvishi1349@gmail.com

Abstract: (2240 Views)

Background and Aim: Since the incidence of various infections caused by Staphylococcus aureus increases, the use of effective antibiotics such as clindamycin has been growing to treat the systemic and local infections caused by such organisms. Antibiotic-resistant species are emerging and spreading in today's communities due to misuse of antibiotics and incomplete treatment, turning into a serious challenge for the health care system of countries, even in the advanced ones. Therefore, this study aims to investigate the prevalence of clindamycin-resistant S. aureus induced by macrolide resistance.
Materials and Methods: In this cross-sectional descriptive study, 117 S. aureus isolates were collected from clinical samples of patients referred to Beâsat Hospital, Aja University of Medical Science, in Tehran, in Jan. 2019 to Jan. 2021, Tehran, Iran and were approved after diagnostic, microbiological, biochemical tests. Then, the data of antibiogram test were collected.
Results and Conclusion: The results showed that 47% and 43% of the isolated samples were resistant to erythromycin and clindamycin, respectively. The prevalence of isolates with erythromycin resistance and induction resistance to clindamycin was approximately 38% and total induction resistance to clindamycin was 12%. The results indicate that antibiogram tests are required to identify induced resistance to clindamycin and to inform physicians about how to prescribe antibiotics in the treatment of infections caused by S. aureus.

Keywords: Staphylococcus aureus, Clindamycin, Drug resistance, Macrolide resistance

Full-Text [PDF 598 kb] (574 Downloads) | | Full-Text (HTML) (232 Views)

Type of Study: Brief Original Article | Subject: Antibiotic Resistance
Received: 2022/08/5 | Accepted: 2023/01/27 | ePublished: 2023/03/30

References

1. Akbari M, Nejad Rahim R, Azimpour A, Bernousi I, Ghahremanlu H. A survey of nosocomial infections in intensive care units in an Imam Reza hospital to provide appropriate preventive guides based on international standards. J Urmia Univ Med Sci. 2013;23(6):591-6.

2. Ak O, Batirel A, Ozer S, Çolakoğlu S. Nosocomial infections and risk factors in the intensive care unit of a teaching and research hospital: a prospective cohort study. Med Sci Monit. 2011;17(5):Ph29-34. [DOI:10.12659/MSM.881750] [PMID] [PMCID]

3. Weinstein RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001;7(2):188-92. [DOI:10.3201/eid0702.010206] [PMID] [PMCID]

4. Weinstein RA. Nosocomial infection Update. Emerg Infect Dis. 1998;4(3):416-20. [DOI:10.3201/eid0403.980320] [PMID] [PMCID]

5. Richards MJ, Edwards JR, Culver DH, Gaynes RP, National Nosocomial Infections Surveillance S. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21(8):510-5. [DOI:10.1086/501795] [PMID]

6. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27(5):887-92. [DOI:10.1097/00003246-199905000-00020] [PMID]

7. Ghorbani F, Saifi B, Mohammadzadeh S, Zare M. Microbiological factors in burn wound infection in patients hospitalized in Zanjan. Iran J Nurs Res. 2011;6(22):65-72.

8. Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I. Detection and prevalence of inducible clindamycin resistance in staphylococci. J Med Microbiol. 2007;56(3):342-5. [DOI:10.1099/jmm.0.46761-0] [PMID]

9. Saderi H, Oulia P, Eslami M. Prevalence of Macrolide-Lincosamide-Streptogramin B (MLSB) resistance in S. aureus isolated from patients in Tehran, Iran. Iran J Pathol. 2009;4(4):161-6.

10. Farahmand S, Haeili M, Darban-Sarokhalil D. Molecular Typing and Drug Resistance Patterns of Staphylococcus aureus Isolated From Raw Beef and Chicken Meat Samples. Iran J Med Microbiol. 2020;14(5):478-89. [DOI:10.30699/ijmm.14.5.478]

11. Lall M, Sahni AK. Prevalence of inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Med J Armed Forces India. 2014;70(1):43-7. [DOI:10.1016/j.mjafi.2013.01.004] [PMID] [PMCID]

12. Abdollahi S, Ramazanzadeh R, Delami Khiabani Z, Kalantar E, Menbari S. Molecular Detection of Inducible Clindamycin Resistance among Staphylococcal Strains Isolated from Hospital Patients. J Res Med Sci. 2013;13(1):59-68.

13. Shoja S, Nahaei MR, Nahaei M. Detection of inducible clidamycin resistance in Staphylococcus aureus and Staphylococcus epidermidis by using D-Test. Pharmacol Sci. 2009;15(11):1-8.

14. Mohan Raj JR, Vittal R, Shivakumaraswamy SK, Deekshit VK, Chakraborty A, Karunasagar I. Presence & mobility of antimicrobial resistance in Gram-negative bacteria from environmental samples in coastal Karnataka, India. Indian J Med Res. 2019;149(2):290-4. [DOI:10.4103/ijmr.IJMR_2088_17] [PMID] [PMCID]

15. Kouchak F, Askarian M. Nosocomial infections: the definition criteria. Iran J Med Sci. 2012;37(2):72-3.

16. Sheng W-H, Wang J-T, Lin M-S, Chang S-C. Risk Factors Affecting In-hospital Mortality in Patients with Nosocomial Infections. J Formos Med Assoc. 2007;106(2):110-8. [DOI:10.1016/S0929-6646(09)60226-6] [PMID]

17. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical Disk Diffusion Method for Detection of Inducible Clindamycin Resistance in Staphylococcus aureus and Coagulase-Negative Staphylococci. J Clin Microbiol. 2003;41(10):4740-4. [DOI:10.1128/JCM.41.10.4740-4744.2003] [PMID] [PMCID]

18. Steward Christine D, Raney Patti M, Morrell Allison K, Williams Portia P, McDougal Linda K, Jevitt L, et al. Testing for Induction of Clindamycin Resistance in Erythromycin-Resistant Isolates of Staphylococcus aureus. J Clin Microbiol. 2005;43(4):1716-21. [DOI:10.1128/JCM.43.4.1716-1721.2005] [PMID] [PMCID]

19. Marr JK, Lim AT, Yamamoto L. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus. Hawaii Med J. 2005;64(1):17-22.